Hormonal, auxological and clinical follow-up in children with connatal HIV infection: Personal records

Minerva Pediatrica

Volumn 58, Issue 5, 2006, Pages 461-467

  Titone, L ^a   Maggio, M C ^a,c   Di Carlo, P ^a   Romano, A ^a   Teresi, S ^b   Guicciardino, E ^b   Saitta, M ^a   Liotta, A ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Hospital G di Cristina   (Italy)

^c NONE   (Italy)

Author keywords

Child; Follow up; HIV infections, diagnosis

Indexed keywords

CLONIDINE; CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; INSULIN; LEPTIN; LIOTHYRONINE; LUTEINIZING HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID ANTIBODY; THYROTROPIN; THYROXINE;

ARTICLE; BODY HEIGHT; BONE MATURATION; CHILD; CHILD GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; FEMALE; FOLLOW UP; HORMONE ACTION; HORMONE RELEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MALE; MEDICAL RECORD; PUBERTY;

BONE DEVELOPMENT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DISEASE TRANSMISSION, VERTICAL; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HORMONES; HUMANS; INFANT; MALE; PUBERTY;

EID: 33750607715     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Kuhn L, Thomas PA, Singh T, Tsai WY. Long-term survival of children with Human immunodeficiency virus infection in New-York city: estimates from population-based surveillance data. Am J Epidemiol 1998;147:846-54.
2. De Martino M, Tovo PA, Balducci M, Galli L, Gabbiano C, Rezza G et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. JAMA 2000;284:190-7.
3. rd et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med 2001;345:1522-8.
4. De Rossi A. Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course. J Biol Regul Homeost Agents 2002;16:53-7.
5. Dreimane D, Nielsen K, Deveikis A, Bryson YJ, Geffner ME. Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 2001;20:315-6.
6. Nadal D, Steiner F, Cheseaux JJ, Rudin C. Ritonavir promotes linear growth in HIV-infected children. AIDS 1998;12:2356-7.
7. Matarazzo P, Paloma E, Lala R, Ciuti E, Altare F, De Sanctis L et al. Growth impairment, IGF I hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection. Acta Paediatr 1994;83:1029-34.
8. Watson DC, Counts DR. Growth hormone deficiency in HIV-infected children following successful treatment with highly active antiretroviral therapy. J Pediatr 2004;145:549-51.
9. Weinberg GA, Jospe N. Growth hormone deficiency and HIV infection. J Pediatr 2005;147:559-60.
10. Laue L, Pizzo PA, Butler K, Cutler GB. Growth and neuroendocrine dysfunction in children with acquired immunodeficiency sindrome. J Pediatr 1990;117:541-5.
11. Centers for disease Control and Prevention. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994;12:1-10.
12. nd ed. Stanford, CA: Stanford University Press; 1959.
13. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls. Arch Dis Child 1969;44:291-303.
14. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in boys. Arch Dis Child 1970;45:13-23.
15. Garcia-Mayor R, Andrade A, Rios M, Lage M, Dieguez C, Casanueva FF. Serum leptin levels in normal children: relationship to age, gender body mess index, pituitary-gonadal hormones, and pubertal stage. J Clin Endocrinol Metab 1997;82:2849-54.
16. Luzuriaga K, McManus M, Catalina M, Mayack S, Sharkey M, Stevenson M et al. Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1 specific immune responses. J Virol 2000;74:6984-91.
17. Lederman MM, Valdez H. Immune restoration with antiretroviral therapies. JAMA 2000;284:223-8.
18. Centers for the Disease Control and Prevention. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. MMWR December 2001.
19. Sharland M, di Zub GC, Ramos JT, Blanche S, Gibb DM; Penta Steering Committee. PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. Pediatric European Network for Treatment of AIDS. HIV Med 2002;3:215-26.
20. The European Collaborative Study. Weight, height and human immunodeficiency virus infection in young children of infected mothers. Pediatr Infect Dis J 1995;14:685-90.
21. Palmer A. Growth failure is important factor in the survival rate of HIV-infected children. HIV Clinician 2003;15:1-4.
22. The European Collaborative Study. Weight, height and human immunodeficiency virus infection in young children of infected mothers. Pediatr Infect Dis J 1995;14:685-90.
23. Miller TL, Evans SJ, Orav EJ, Morris V, McIntosh K, Winter HS. Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr 1993;57:588-92.
24. Dreimane D, Meisen K, Deveikis A, Bryson YJ, Geffner ME. Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in Human Immunodeficiency Virus type-1 infected children. Pediatr Infect Dis J 2001;20:315-6.
25. Rondanelli M, Caselli D, Maccabruni A, Maghnie M, Bacchella L, De Stefano A et al. Involvement of hormonal circadian secretion in the growth of HIV-infected children. AIDS 1998;12:6885-90.
26. Rondanelli M, Caselli D, Arico M, Maccabruni A, Magnani B, Bacchella L et al. Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein 3 response to Growth Hormone is impaired in HIV-infected children. AIDS 2002;18:331-9.
27. Frost RA, Nachman SA, Lang CH, Gelato MC. Proteolysis of insulin-like growth factor-binding protein -3 in human immunodeficiency virus-positive children who fail to thrive. J Clin Endocrinol Metab 1996;81:2957-62.
28. Paganelli R, Mezzaroma I, Mazzone AM, Pinter E, Aiuti F. Leptin levels in HIV-positive patients treated with HAART. AIDS 1999;13:2479-92.
29. Matarese G, Castelli-Gattinara G, Cancrini C, Bernardi S, Romiti ML, Savarese C et al. Serum leptin and CD4+ T lymphocytes in HIV+ children during highly active antiretroviral therapy. Clin Endocrinol 2002;57:643-6.
30. Liotta A, Maggio MC, Di Carlo P, A Romano, PM Miraglia and Titone L. Serum Leptin and Interleukin-6 Levels in Pediatric Patients with HIV. J Pediatr Endocrinol Metab 2003;16:179-83.
31. Ockenga J, Widjaja A, Holmannspotter M, Schmidt RE, Brabant G. Bound leptin is regulated by tumour necrosis factor-α in HIV-infected patients: a potential mediator of wasting? AIDS 1998;12:2233-5.
32. Zumbach MS, Boheme WJ, Wahl P, Stremmel W, Ziegler R, Nawroth PP. Tumor necrosis factor increases serum leptin levels in humans. J Clin Endocrinol Metab 1997;82:4080-2.
33. Van Rossum AM, Gaakeer MI, Verweel S, Hartwig NG, Wolfs TF, Geelen SP et al. Endocrinologic and immunologic factors associated with recovery of growth in children with human immunodeficiency virus type 1 infection treated with protease inhibitors. Pediatr Infect Dis J 2003;22:70-6.